These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 37564261)
1. Retracted: Integrative Nomogram of Computed Tomography Radiomics, Clinical, and Tumor Immune Features for Analysis of Disease-Free Survival of NSCLC Patients with Surgery. Oncology JO J Oncol; 2023; 2023():9832601. PubMed ID: 37564261 [TBL] [Abstract][Full Text] [Related]
2. Integrative Nomogram of Computed Tomography Radiomics, Clinical, and Tumor Immune Features for Analysis of Disease-Free Survival of NSCLC Patients with Surgery. Xiu D; Mo Y; Liu C; Hu Y; Wang Y; Zhao Y; Guo T; Cheng K; Huang C; Liu L; Cheng M J Oncol; 2023; 2023():8607062. PubMed ID: 36866239 [TBL] [Abstract][Full Text] [Related]
3. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer. Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940 [TBL] [Abstract][Full Text] [Related]
4. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients. Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451 [TBL] [Abstract][Full Text] [Related]
5. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis. Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270 [TBL] [Abstract][Full Text] [Related]
6. CT-based radiomics for predicting brain metastases as the first failure in patients with curatively resected locally advanced non-small cell lung cancer. Sun F; Chen Y; Chen X; Sun X; Xing L Eur J Radiol; 2021 Jan; 134():109411. PubMed ID: 33246270 [TBL] [Abstract][Full Text] [Related]
7. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer. Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009 [TBL] [Abstract][Full Text] [Related]
8. Retracted: Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC. Imaging CMM Contrast Media Mol Imaging; 2023; 2023():9812821. PubMed ID: 37810478 [TBL] [Abstract][Full Text] [Related]
9. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma. Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012 [TBL] [Abstract][Full Text] [Related]
10. A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population. Wang L; Liu A; Wang Z; Xu N; Zhou D; Qu T; Liu G; Wang J; Yang F; Guo X; Chi W; Xue F Front Oncol; 2022; 12():816766. PubMed ID: 35774128 [TBL] [Abstract][Full Text] [Related]
11. Radiomics nomogram for the prediction of Ki-67 index in advanced non-small cell lung cancer based on dual-phase enhanced computed tomography. Sun H; Zhou P; Chen G; Dai Z; Song P; Yao J J Cancer Res Clin Oncol; 2023 Sep; 149(11):9301-9315. PubMed ID: 37204513 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer. Chen Q; Shao J; Xue T; Peng H; Li M; Duan S; Feng F Eur Radiol; 2023 Feb; 33(2):947-958. PubMed ID: 36064979 [TBL] [Abstract][Full Text] [Related]
13. Computed Tomography-based Radiomics Nomogram for the Preoperative Prediction of Tumor Deposits and Clinical Outcomes in Colon Cancer: a Multicenter Study. Li M; Xu G; Chen Q; Xue T; Peng H; Wang Y; Shi H; Duan S; Feng F Acad Radiol; 2023 Aug; 30(8):1572-1583. PubMed ID: 36566155 [TBL] [Abstract][Full Text] [Related]
14. Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram. Li R; Peng H; Xue T; Li J; Ge Y; Wang G; Feng F Clin Radiol; 2022 Mar; 77(3):e222-e230. PubMed ID: 34974912 [TBL] [Abstract][Full Text] [Related]
15. Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma. Xie D; Wang TT; Huang SJ; Deng JJ; Ren YJ; Yang Y; Wu JQ; Zhang L; Fei K; Sun XW; She YL; Chen C Transl Lung Cancer Res; 2020 Aug; 9(4):1112-1123. PubMed ID: 32953490 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection. Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171 [TBL] [Abstract][Full Text] [Related]
17. Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy. Zhang J; Jin J; Ai Y; Zhu K; Xiao C; Xie C; Jin X Front Oncol; 2020; 10():610691. PubMed ID: 33643912 [TBL] [Abstract][Full Text] [Related]
18. Radiomics Nomogram for Predicting Locoregional Failure in Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiotherapy. Chen X; Tong X; Qiu Q; Sun F; Yin Y; Gong G; Xing L; Sun X Acad Radiol; 2022 Feb; 29 Suppl 2():S53-S61. PubMed ID: 33308945 [TBL] [Abstract][Full Text] [Related]
19. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer. Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764 [TBL] [Abstract][Full Text] [Related]
20. A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma. Lin P; Wen DY; Chen L; Li X; Li SH; Yan HB; He RQ; Chen G; He Y; Yang H Eur Radiol; 2020 Jan; 30(1):547-557. PubMed ID: 31396730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]